A Merck KGaA, Darmstadt, Germany, researcher at work. Merck KGaA has agreed to acquire Bio-Techne for approximately $11.3 billion, in a deal designed to position the buyer as more of a leader across ...
Panelists during the FDA town hall at BIO 2026. (L to R) Lowell Zeta, JD, acting chief of staff at the FDA; Karim Mikhail, CBER acting director; Michael Davis, MD, PhD, CDER acting director [Uduak ...
Med-tech M&As through the first half (H1) of 2026 reached $75.73 billion in collective value, the highest H1 total since 2022’s $120.4 billion and well above every other year in BioWorld’s records.
Med-tech M&As through the first half (H1) of 2026 reached $75.73 billion in collective value, the highest H1 total since 2022’s $120.4 billion and well above every other year in BioWorld’s records.
Dune 3 – officially titled Dune: Part Three – is only months away as we'll be heading back to Arrakis this December. We're waiting patiently for a new trailer, and it seems we'll be getting one soon ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results